Trial Profile
LY2216684 and Sertraline Pharmacokinetic Interaction Study in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Edivoxetine (Primary) ; Sertraline
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 27 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Dec 2010 New trial record